Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop
Journal
Leukemia and Lymphoma
Journal Volume
59
Journal Issue
10
Pages
2305-2317
Date Issued
2018
Author(s)
Tan D.
Lee J.H.
Chen W.
Shimizu K.
Hou J.
Suzuki K.
Nawarawong W.
Sang Chim C.
Kim K.
Kumar L.
Malhotra P.
Chng W.J.
Durie B.
for the Asian Myeloma Network
Abstract
Predicated on our improved understanding of the disease biology, we have seen remarkable advances in the management of multiple myeloma over the past few years. Recently approved drugs have radically transformed the treatment paradigm and improved survivals of myeloma patients. The progress has necessitated revision of the diagnostic criteria, risk-stratification and response definition. The huge disparities in economy, healthcare infrastructure and access to novel drugs among different Asian countries will hinder the delivery of optimum myeloma care to patients managed in resource-constrained environments. In the light of the tremendous recent changes and evolution in myeloma management, it is timely that the resource-stratified guidelines from the Asian Myeloma Network be revised to provide updated recommendations for Asia physicians practicing under various healthcare reimbursement systems. This review will highlight the most recent advances and our recommendations on how they could be integrated in both resource-abundant and resource-constrained facilities. ? 2018, ? 2018 Informa UK Limited, trading as Taylor & Francis Group.
Subjects
Myeloma; novel agents; resource-stratified
SDGs
Other Subjects
Asia; cancer diagnosis; cancer patient; cancer recurrence; clinical trial (topic); Conference Paper; consensus development; human; multiple myeloma; patient care; priority journal; consensus; drug resistance; economics; health care delivery; health care disparity; health care organization; international cooperation; multiple myeloma; oncology; practice guideline; procedures; risk assessment; standards; stem cell transplantation; trends; tumor recurrence; antineoplastic agent; Antineoplastic Agents; Asia; Consensus; Consensus Development Conferences as Topic; Drug Resistance, Neoplasm; Health Care Rationing; Health Services Accessibility; Healthcare Disparities; Humans; International Cooperation; Medical Oncology; Multiple Myeloma; Neoplasm Recurrence, Local; Practice Guidelines as Topic; Risk Assessment; Stem Cell Transplantation
Publisher
Taylor and Francis Ltd
Type
conference paper